PA
PACB icon

Profund Advisors’s Pacific Biosciences PACB Stock Holding History

Profund Advisors’s Portfolio PACB Stock Details PACB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-30,448
Closed -$135K – 995
2022
Q2 		$135K Sell
30,448
-2,785
-8% -$16.9K 0.01% 955
2022
Q1 		$302K Sell
33,233
-3,672
-10% -$42.3K 0.01% 923
2021
Q4 		$755K Sell
36,905
-1,056
-3% -$25.5K 0.02% 421
2021
Q3 		$970K Buy
37,961
+32,252
+565% +$956K 0.03% 369
2021
Q2 		$200K Buy
+5,709
New +$166K 0.01% 1359

Other funds holding PACB

AIM
ARK Investment Management St. Petersburg, Florida $12.9B AUM 64.92% 1-Year Est. Return
JSP
Jackson Square Partners Larkspur, California $247M AUM 20.29% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
NAMA
Nikko Asset Management Americas New York $7.07B AUM 50.91% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $154B AUM 29.96% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
BG
Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Profund Advisors's PACB Position: Q3 2022 in Review

Profund Advisors sold out of Pacific Biosciences (PACB) in Q3 2022, closing a stake of 30,448 shares — an estimated $135K sold.

Profund Advisors first reported a position in PACB in Q2 2021 and held it in 5 quarters. The position peaked at $970K in Q3 2021. 227 funds tracked by Wall St. Rank hold PACB as of Q3 2022.

  • Profund Advisors reported no remaining Pacific Biosciences position as of Q3 2022 after selling out during the quarter.
  • Profund Advisors sold 30,448 Pacific Biosciences shares in Q3 2022, an estimated $135K.
  • Profund Advisors first reported a position in Pacific Biosciences in Q2 2021 and held it in 5 quarters.
  • Profund Advisors's Pacific Biosciences position peaked at $970K in Q3 2021.
  • 227 funds tracked by Wall St. Rank held Pacific Biosciences as of Q3 2022.

Based on Profund Advisors's 13F filing for Q3 2022, filed 7 Nov 2022.